Amneal Pharmaceuticals, Inc. revenue breakdown overview

Amneal Pharmaceuticals, Inc. revenue for the last year amounted to 2.39 B USD, the most of which — 1.47 B USD — came from its highest performing source at the moment, Generics, the year earlier bringing 1.43 B USD. The greatest contribution to the revenue figure was made by United States, India and Ireland — last year it brought Amneal Pharmaceuticals, Inc. 2.39 B USD, and the year before that — 2.21 B USD.